Gilead Sciences (GILD) PT Lowered to $65 at Credit Suisse
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $145.94 -1.12%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Credit Suisse analyst Evan Seigerman lowered the price target on Gilead Sciences (NASDAQ: GILD) to $65.00 (from $70.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Analog Devices (ADI) PT Raised to $500 at JPMorgan
- Shanghai Conant Optical (2276:HK) PT Lowered to HK$81.40 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
